Loading
Lung screening is a teachable moment. Giving cessation medicine and support by default at every scan, unless the person opts out, roughly doubles quit rates.
Lung screening is a teachable moment, so this idea makes opt-out cessation pharmacotherapy, varenicline or cytisine, plus counselling a programme standard at every low-dose CT visit, with quit rate as a headline performance indicator. Opt-out cessation in screening programmes such as the YESS trial improves quit rates, cessation delivers more life-years than the scan itself in modelling, and the population is captive. The aim is to roughly double biochemically verified quit rates among screened smokers at one year. The test is a programme-level comparison plus an RCT of opt-out versus opt-in delivery. Being tested at scale, it addresses the bottleneck Prevention we already have is not deployed and links to smoking cessation in cancer patients.
One bottleneck page and 27 idea pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Smoking is the single largest preventable cause of cancer death, and quitting at any age helps, with the greatest gain from quitting young. Cessation support belongs in every cancer service, including lung screening programmes.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed, Non-small-cell lung cancer.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed, Non-small-cell lung cancer.
Shares Fifty years of the British Doctors Study: smokers lose ten years of life, quitting gives most of it back, Smoking cessation in cancer patients, Prevention we already have is not deployed, Non-small-cell lung cancer.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Fifty years of the British Doctors Study: smokers lose ten years of life, quitting gives most of it back, Prevention we already have is not deployed, Non-small-cell lung cancer.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.
Shares Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States, Prevention we already have is not deployed.